PubRank

Dietmar Krex

Author PubWeight™ 35.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. J Clin Oncol 2009 3.65
2 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res 2011 2.36
3 Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet 2010 1.86
4 Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer 2010 1.66
5 CpG island hypermethylation in human astrocytomas. Cancer Res 2010 1.57
6 Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Oncogene 2004 1.48
7 Frequent epigenetic inactivation of the SLIT2 gene in gliomas. Oncogene 2003 1.47
8 The stem cell marker prominin-1/CD133 on membrane particles in human cerebrospinal fluid offers novel approaches for studying central nervous system disease. Stem Cells 2007 1.21
9 Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups. Acta Neuropathol 2015 1.16
10 Common variant near the endothelin receptor type A (EDNRA) gene is associated with intracranial aneurysm risk. Proc Natl Acad Sci U S A 2011 1.08
11 IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas. J Neurooncol 2012 1.04
12 Current status of local therapy in malignant gliomas--a clinical review of three selected approaches. Pharmacol Ther 2013 1.04
13 Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker? Clin Cancer Res 2007 1.03
14 RRP22 is a farnesylated, nucleolar, Ras-related protein with tumor suppressor potential. Cancer Res 2005 0.99
15 Frequent epigenetic inactivation of KIBRA, an upstream member of the Salvador/Warts/Hippo (SWH) tumor suppressor network, is associated with specific genetic event in B-cell acute lymphocytic leukemia. Epigenetics 2011 0.99
16 Favorable outcome in the elderly cohort treated by concomitant temozolomide radiochemotherapy in a multicentric phase II safety study of 5-ALA. J Neurooncol 2010 0.98
17 Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide. J Neurooncol 2009 0.96
18 Differential retinoic acid signaling in tumors of long- and short-term glioblastoma survivors. J Natl Cancer Inst 2011 0.94
19 DNA methylation profiles of long- and short-term glioblastoma survivors. Epigenetics 2013 0.94
20 Accumulation of 2-hydroxyglutarate is not a biomarker for malignant progression in IDH-mutated low-grade gliomas. Neuro Oncol 2013 0.90
21 Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression. J Neurooncol 2014 0.87
22 End-of-life caregivers' perception of medical and psychological support during the final weeks of glioma patients: a questionnaire-based survey. Neuro Oncol 2013 0.87
23 RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells. Epigenetics 2014 0.84
24 Postoperative cerebellar mutism in adult patients with Lhermitte-Duclos disease. Neurosurg Rev 2010 0.83
25 Polymorphisms of homocysteine metabolism are associated with intracranial aneurysms. Cerebrovasc Dis 2008 0.83
26 Tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphisms in a Caucasian population with abdominal aortic aneurysm. World J Surg 2007 0.82
27 Stability of the CpG island methylator phenotype during glioma progression and identification of methylated loci in secondary glioblastomas. BMC Cancer 2014 0.82
28 Epigenetic markers in human gliomas: prospects for therapeutic intervention. Expert Rev Neurother 2008 0.80
29 RET-protooncogene variants in patients with sporadic neoplasms of the digestive tract and the central nervous system. Int J Colorectal Dis 2011 0.78
30 Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing. PLoS One 2013 0.78
31 Is there pseudoprogression in secondary glioblastomas? Int J Radiat Oncol Biol Phys 2013 0.77
32 Safety and Effectiveness of Bis-Chloroethylnitrosourea Wafer Chemotherapy in Elderly Patients with Recurrent Glioblastoma. Oncology 2017 0.75